ITRM
Iterum Therapeutics Plc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.17
+0.00 +0.82%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$0.17
+0.00 +0.64%
| Index | - | P/E | - | EPS (ttm) | -0.75 | Insider Own | 0.79% | Shs Outstand | 0.05B | Perf Week | 4.23% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 53.03% | Insider Trans | 1.46% | Shs Float | 0.05B | Perf Month | -42.28% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.14 | Inst Own | 3.65% | Short Float | 3.9% | Perf Quarter | -62.5% |
| Income | -0.03B | P/S | 23.36 | EPS this Y | 25.84% | Inst Trans | 0.68% | Short Ratio | 1.84 | Perf Half Y | -75.67% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 22.77% | ROA | -111.35% | Short Interest | 2.05M | Perf YTD | -48.51% |
| Book/sh | -0.15 | P/C | 0.83 | EPS past 3/5Y | 46.92% 58.85% | ROE | - | 52W High | -88.5% ($1.50) | Perf Year | -87.13% |
| Cash/sh | 0.21 | P/FCF | - | Sales past 3/5Y | - | ROIC | -103.41% | 52W Low | 27.12% ($0.14) | Perf 3Y | -82.9% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 62.61% | Gross Margin | -483.85% | Volatility(W/M) | 8.97% 15.13% | Perf 5Y | -99.26% |
| Dividend TTM | - | EV/Sales | 81.67 | Sales Y/Y TTM | - | Oper. Margin | -5292.31% | ATR (14) | 0.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.96 | EPS Q/Q | 35.53% | Profit Margin | -6913.08% | RSI (14) | 36.76 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.13 | Sales Q/Q | - | SMA20 | -17.85% ($0.21) | Beta | 3.08 | Target Price | $9 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -38.2% ($0.28) | Rel Volume | 0.44 | Prev Close | $0.17 |
| Employees | 9 | LT Debt/Eq | - | EPS/Sales Surpr. | -77.78% - | SMA200 | -71.5% ($0.6) | Avg Volume(3M) | 1.11M | Price | $0.17 |
| IPO | 2018/5/25 | Option/Short | No/Yes | Trades | 288 | Volume | 488,620 | Change | 0.82% |
뉴스 로딩 중...